News + Resources
Keep up with the latest
Featured
Recent
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
This Scientist Is Building Custom Gene-Editing Tools
November 11, 2024
This Scientist Is Building Custom Gene-Editing Tools
November 11, 2024
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
All Stories
News
Engineering the Future of Genetic Medicine
September 10, 2024
The Scientistt Podcast
Read Now
Press
Engineering the Future of Genetic Medicine
September 10, 2024
The Scientistt Podcast
Read Now
News
Engineering The Future Of Genetic Medicine
September 10, 2024
Progress, Potential, and Possibilities
Read Now
Press
Engineering The Future Of Genetic Medicine
September 10, 2024
Progress, Potential, and Possibilities
Read Now
News
Leadership essentials: “Inspire, motivate, and cultivate”
September 9, 2024
BigThink
Read Now
Press
Leadership essentials: “Inspire, motivate, and cultivate”
September 9, 2024
BigThink
Read Now
News
Small Enzymes, Giant Leaps: CRISPR’s Next-Generation Approach to Genetic Diseases
August 5, 2024
BioSpace
Read Now
Press
Small Enzymes, Giant Leaps: CRISPR’s Next-Generation Approach to Genetic Diseases
August 5, 2024
BioSpace
Read Now